|
HY-103081-10mg
|
MedChemexpress LLC
|
Beta-Glucuronidase-IN-1 [CAS 484006-66-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-103081-5mg
|
MedChemexpress LLC
|
Beta-Glucuronidase-IN-1 [CAS 484006-66-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-109785A-1mg
|
MedChemexpress LLC
|
(R)-Gyramide A (hydrochloride) [CAS 1793050-70-0]
|
|
|
|
|
HY-110354-10mg
|
MedChemexpress LLC
|
UCM05 [CAS 1094451-90-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-110354-100mg
|
MedChemexpress LLC
|
UCM05 [CAS 1094451-90-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-110354-25mg
|
MedChemexpress LLC
|
UCM05 [CAS 1094451-90-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-110354-5mg
|
MedChemexpress LLC
|
UCM05 [CAS 1094451-90-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-110354-50mg
|
MedChemexpress LLC
|
UCM05 [CAS 1094451-90-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-116572A-10mg
|
MedChemexpress LLC
|
TASIN-1 [CAS 792927-06-1]
|
|
Cancer-programmed cell death
|
|
|
HY-116572A-100mg
|
MedChemexpress LLC
|
TASIN-1 [CAS 792927-06-1]
|
|
Cancer-programmed cell death
|
|
|
HY-116572A-25mg
|
MedChemexpress LLC
|
TASIN-1 [CAS 792927-06-1]
|
|
Cancer-programmed cell death
|
|
|
HY-116572A-5mg
|
MedChemexpress LLC
|
TASIN-1 [CAS 792927-06-1]
|
|
Cancer-programmed cell death
|
|
|
HY-116572A-50mg
|
MedChemexpress LLC
|
TASIN-1 [CAS 792927-06-1]
|
|
Cancer-programmed cell death
|
|
|
HY-116788-10mg
|
MedChemexpress LLC
|
Lipofermata [CAS 297180-15-5]
|
|
Cancer-programmed cell death
|
|
|
HY-116788-100mg
|
MedChemexpress LLC
|
Lipofermata [CAS 297180-15-5]
|
|
Cancer-programmed cell death
|
|
|
HY-116788-25mg
|
MedChemexpress LLC
|
Lipofermata [CAS 297180-15-5]
|
|
Cancer-programmed cell death
|
|
|
HY-116788-5mg
|
MedChemexpress LLC
|
Lipofermata [CAS 297180-15-5]
|
|
Cancer-programmed cell death
|
|
|
HY-116788-50mg
|
MedChemexpress LLC
|
Lipofermata [CAS 297180-15-5]
|
|
Cancer-programmed cell death
|
|
|
HY-118211-250mg
|
MedChemexpress LLC
|
EcDsbB-IN-9 [CAS 41933-33-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-118827-1mg
|
MedChemexpress LLC
|
Vedaprofen [CAS 71109-09-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-118827-10mg
|
MedChemexpress LLC
|
Vedaprofen [CAS 71109-09-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-118827-100mg
|
MedChemexpress LLC
|
Vedaprofen [CAS 71109-09-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-118827-25mg
|
MedChemexpress LLC
|
Vedaprofen [CAS 71109-09-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-118827-5mg
|
MedChemexpress LLC
|
Vedaprofen [CAS 71109-09-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-118827-50mg
|
MedChemexpress LLC
|
Vedaprofen [CAS 71109-09-6]
|
|
COVID-19-immunoregulation
|
|
